Latest filing published 30 Nov 2020 for Biolife Solutions INC, €30.4M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -54.0%Entry US$5.04 · Close at T+365 US$2.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas Girschweiler: trading record in brief
Thomas Girschweiler discloses dealings in Biolife Solutions Inc to SEC (Form 4). The record holds 37 filings, for trades running from 31 December 2005 to 24 November 2020.
Market trades split into 2 purchases (€201k) and 9 sales (€55.1M). Taken together, the sales exceed the purchases by €54.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 18 share grants and 4 option exercises. So far in 2020, the count stands at no purchases and 5 sales.
The newest entry dates from 30 November 2020: an open-market sale of €30.4M, in Biolife Solutions Inc. The latest purchase dates back some time: it was published 4,942 days ago, on 29 April 2013. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas Girschweiler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,600,000 shares@ US$22.5055.5% of flowCommon StockSEC:0001437749-20-024588:0
- 5,000 sharesCommon StockSEC:0001437749-20-020872:0
- 305,583 shares@ US$14.507.2% of flowCommon StockSEC:0001437749-20-014578:0
- 162,760 shares@ US$15.364.2% of flowCommon StockSEC:0001437749-20-012378:1
- 1,544,194 shares@ US$4.7512.4% of flowCommon StockSEC:0001437749-20-012378:2
- 492,277 shares@ US$14.9012.4% of flowCommon StockSEC:0001437749-20-012378:3
- 476,191 shares@ US$10.508.3% of flowCommon StockSEC:0001437749-20-012378:4
- 10,714 shares@ US$1.2610.0% of flowCommon StockSEC:0001437749-20-012378:0
- 10,714 shares@ US$1.4010.0% of flowCommon StockSEC:0001437749-20-001603:0
- 33,143 shares@ US$11.370.5% of flowCommon StockSEC:0001437749-18-013144:0
- 252,571 shares@ US$11.373.9% of flowCommon StockSEC:0001437749-18-013144:1
- 1,000,000 shares@ US$5.266.9% of flowCommon StockSEC:0001437749-18-006639:0
- 25,000 shares@ US$5.260.2% of flowCommon StockSEC:0001437749-18-006639:1
- 10,000 sharesCommon StockSEC:0001144204-18-000667:0
- 834 sharesCommon StockSEC:0001144204-18-000667:1
- 887 sharesCommon StockSEC:0001144204-17-051153:0
- 2,092 sharesCommon StockSEC:0001144204-17-036094:0
- 71,429 shares@ US$1.120.1% of flowCommon StockSEC:0001144204-17-029845:0
- 2,381 sharesCommon StockSEC:0001144204-17-019305:0
- 17,857 shares@ US$1.120.0% of flowCommon StockSEC:0001144204-17-007170:0
- 3,106 sharesCommon StockSEC:0001144204-17-002791:0
- 71,428 shares@ US$0.840.1% of flowCommon SharesSEC:0001140361-16-077855:0
- 71,429 shares@ US$0.98Common SharesSEC:0001354488-15-005375:0
- 1,544,194 sharesCommon StockSEC:0001140361-14-014272:0
- 1,761,827 shares@ US$0.12Common SharesSEC:0001354488-13-002288:0Canonical exit: 31 Mar 2006 (T+90)
25 of 36 declarations
